P
US7019148B2ExpiredUtilityPatentIndex 73

Synthesis of irbesartan

Assignee: TEVA PHARMAPriority: Jan 16, 2003Filed: Jan 16, 2004Granted: Mar 28, 2006
Est. expiryJan 16, 2023(expired)· nominal 20-yr term from priority
Inventors:NISNEVICH GENNADYRUKHMAN IGORPERTSIKOV BORISKAFTANOV JULIADOLITZKY BEN ZION
C07D 403/10C07D 235/02
73
PatentIndex Score
7
Cited by
15
References
3
Claims

Abstract

Provided are a method of making irbesartan via a Suzuki coupling reaction and a novel intermediate, 2-butyl-3-(4′-bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one, for such process. The novel process includes the step of reacting such intermediate with a protected imidazolephenylboronic acid.

Claims

exact text as granted — not AI-modified
1. A process for preparing irbesartan comprising the steps of:
 a) providing a solution of 2-butyl-3-[2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl methyl]-1,3-diazaspiro[4.4]non-1-ene-4-one in a water miscible solvent; 
 b) acidifying the solution; 
 c) neutralizing the solution and separating the trityl alcohol, whereby a second solution is obtained 
 d) acidifying the second solution; 
 e) cooling the acidified second solution; and 
 f) recovering irbesartan. 
 
     
     
       2. The process of  claim 1 , wherein the water miscible solvent in step a is acetone. 
     
     
       3. The process of  claim 1 , wherein the second solution is cooled to about 0° C. to about (−4° C.).

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.